1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends

Healthcare News - Vital Signs - The Analyst’s Perspective - April Issue

  • April 2014
  • 6 pages
  • Frost & Sullivan
Report ID: 2115025

Summary

Table of Contents

This issue of Vital Signs, released on May 1, 2014, discusses the mega deals brewing in the pharma/biotech industry, Pfizer Inc’s Xalkori for non-small cell lung cancer, Novartis' halt on RNAi development efforts, the high-ranked Malaysian healthcare system, Roche's acquisition of IQuum's Liat Analyzer, and Bio-Rad's acquisition of GnuBio.

Deals, a Joint Venture and a Mega Deal Brewing….

Novartis to Buy Glaxo Cancer Drugs; Joint Venture Between Glaxo and Novartis for Consumer Products; Eli Lilly’s Elanco Snags Novartis’s Animal Health Unit in $5.4 Billion Deal; AstraZeneca Cancer Pipeline Seen as Draw for Pfizer.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cutaneous Squamous cell Carcinoma- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025

  • $ 6950
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s ‘Cutaneous Squamous Cell Carcinoma (cSCC) - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025’ report provides provides the comprehensive insights on the ...

Cutaneous Squamous cell Carcinoma (CsCC) - Market Insights, Epidemiology and Market Forecast – 2025

  • $ 5750
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s “Cutaneous Squamous cell Carcinoma (CsCC) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Cutaneous ...

Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market

  • $ 4200
  • Industry report
  • May 2017
  • by Kalorama Information

Potential Pipeline Disruptors: Innovative Pharmaceuticals in Alzheimer's Disease, Asthma and Cancer This report covers market opportunities based on pipeline developments for six key therapeutic specialities: ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.